Argus
http://www.argusresearch.com/Argus is an independent equity research firm with approximately 500 leading US companies across more than 60 industries in its coverage universe. The firm employs a simple Buy, Hold, and Sell rating system to reflect its outlook on companies.
-
Pre-Open Movers 03/08: (ESRX) (BBRG) (EYES) Higher; (VBLT) (MYO) (MEET) Lower (more...)
-
UPDATE: Argus Upgrades Humana (HUM) to Buy
-
Notable Analyst Rating Changes 11/11: (CNX) (TIF) (DECK) Upgraded; (SPWR) (WUBA) (CYH) Downgraded
-
Argus Downgrades Humana (HUM) to Hold
-
Notable 52-Week Highs and Lows 2/23: (TSEM) (JBLU) (ZIOP) High; (SPPI) (DNOW) (FUEL) Low
-
Humana (HUM) PT, Estimates Raised at Argus
-
Notable Analyst Rating Changes 06/06: (JOY) (CNX) (HUM) Upgraded; (BTU) (FTR) (SFY) Downgraded
-
Argus Upgrades Humana (HUM) to Buy
-
Notable Analyst Rating Changes 03/19: BBY, TTEK, PGR, MAR, MCK Upgraded; PALM, FFIV, DTV, SPWRA, WFT, BPFH, HUM Downgraded
-
Argus Downgrades Humana (HUM) to Hold
-
David Moenning's Daily State of the Markets: 4/27
-
Morning Movers 1/13: ZymoGenetics (ZGEN) Up On Bristol-Myers Deal; Lexmark (LXK) Down On Guidance